Reference
Widmer F, et al. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. Annals of Hematology 97: 277-287, No. 2, Feb 2018. Available from: URL: http://doi.org/10.1007/s00277-017-3180-x - Switzerland
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1697, 271 (2018). https://doi.org/10.1007/s40278-018-44827-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44827-z